Search - tctmd.com

Displaying 21 - 40 of 559

Sort: Relevancy | Date

Presentation TCT 2025

TCT 862: The Prognostic Impact of Tricuspid Regurgitation Improvement after Left-sided Valvular Interventions

Presenter: Ina von der Heide

October 27, 2025

News Conference News TCT 2025

More Data on Tricuspid Valve Interventions Reassure, yet Questions Remain

Yael L. Maxwell

October 26, 2025

Presentation TCT 2025

Preprocedural Planning for SHD Interventions: From Valve Sizing to Anatomical Fitting (Laralab)

Presenter: Omar K. Khalique

October 26, 2025

News Conference News TCT 2025

TTVR Remains Safe, Effective in Presence of CIED Leads

Todd Neale

October 25, 2025

Presentation TCT 2025

TCT 630: Transcatheter Aortic Valve Interventions in Patients ≤65 Years of Age: Risk and Outcomes

Presenter: J. Hunter Mehaffey

October 25, 2025

Presentation TCT 2025

TCT 16: National Trends in Mechanical Circulatory Support Utilization During Transcatheter Valve Interventions: A Contemporary U.S. Experience

Presenter: Montaser Elkholy

October 25, 2025

Presentation TCT 2025

Beyond Valves: What is The Next Frontier(s) in Structural Heart Innovation?

Presenter: James M. McCabe

October 25, 2025

Presentation TCT 2025

Outcomes of Transcatheter Tricuspid Valve Replacement in Patients with and without Cardiac Implantable Electronic Devices

Presenter: Santiago Garcia

October 25, 2025

Presentation TCT 2025

Clinical Outcomes of the LuX-Valve Plus Transjugular Tricuspid Valve Replacement System: 6-Month Results of the TRINITY Trial

Presenter: Thomas Elie Modine

October 25, 2025

Presentation TCT 2025

Outcomes of the J-Valve TAVR System for Chronic Aortic Regurgitation: Two-Year Results of An Prospective Multicenter, Single-Arm Study

Presenter: Jian'an Wang

October 25, 2025

News Conference News TCT 2024

TRISCEND II: Full Results a Win for TTVR in Severe Tricuspid Regurgitation

Michael O'Riordan

October 30, 2024

Presentation TCT 2024

Patient-Reported Outcomes are a True Measure of TTVI Value

Presenter: John Spertus

October 30, 2024

Presentation TCT 2024

CV Event Reduction is the Essential Criterion for Implementing New Device Therapies

Presenter: Ori Ben-Yehuda

October 30, 2024

Presentation TCT 2024

Real World TTVI Registries vs. Randomized Trials: Are the Outcomes Aligned?

Presenter: Brian Whisenant

October 30, 2024

Presentation TCT 2024

Transcatheter Tricuspid Valve Replacement - Lessons Learned From TRISCEND II

Presenter: Charles Davidson

October 30, 2024

Presentation TCT 2024

Transcatheter Tricuspid Edge-To-Edge-Repair – Updates from TRILUMINATE and TRI-FR

Presenter: Paul Sorajja

October 30, 2024

Presentation TCT 2024

TCT 834: Percutaneous Coronary Interventions in Patients With Prior Transcatheter Aortic Valve Replacement

Presenter: Chloe Kharsa

October 30, 2024

Presentation TCT 2024

TCT 972: Short Term Outcomes of Transcatheter Tricuspid Valve Interventions on Post-Procedural Length of Hospital Stay, Readmission for HF and Procedure Success if an Intracardiac Device Is Present

Presenter: Dilesha Kumanayaka

October 29, 2024

Presentation TCT 2024

TCT 944: Left Ventricular Outflow Tract Impact on Transcatheter Mitral Valve Interventions

Presenter: Nicholas Sturla

October 29, 2024

Presentation TCT 2024

Transcatheter Tricuspid Valve Interventions in Denmark with 4D ICE imaging

Presenter: Ole De Backer

October 29, 2024

Advertisement

TCT 862: The Prognostic Impact of Tricuspid Regurgitation Improvement after Left-sided Valvular Interventions

More Data on Tricuspid Valve Interventions Reassure, yet Questions Remain

Preprocedural Planning for SHD Interventions: From Valve Sizing to Anatomical Fitting (Laralab)

TTVR Remains Safe, Effective in Presence of CIED Leads

TCT 630: Transcatheter Aortic Valve Interventions in Patients ≤65 Years of Age: Risk and Outcomes

TCT 16: National Trends in Mechanical Circulatory Support Utilization During Transcatheter Valve Interventions: A Contemporary U.S. Experience

Beyond Valves: What is The Next Frontier(s) in Structural Heart Innovation?

Outcomes of Transcatheter Tricuspid Valve Replacement in Patients with and without Cardiac Implantable Electronic Devices

Clinical Outcomes of the LuX-Valve Plus Transjugular Tricuspid Valve Replacement System: 6-Month Results of the TRINITY Trial

Outcomes of the J-Valve TAVR System for Chronic Aortic Regurgitation: Two-Year Results of An Prospective Multicenter, Single-Arm Study

TRISCEND II: Full Results a Win for TTVR in Severe Tricuspid Regurgitation

Patient-Reported Outcomes are a True Measure of TTVI Value

CV Event Reduction is the Essential Criterion for Implementing New Device Therapies

Real World TTVI Registries vs. Randomized Trials: Are the Outcomes Aligned?

Transcatheter Tricuspid Valve Replacement - Lessons Learned From TRISCEND II

Transcatheter Tricuspid Edge-To-Edge-Repair – Updates from TRILUMINATE and TRI-FR

TCT 834: Percutaneous Coronary Interventions in Patients With Prior Transcatheter Aortic Valve Replacement

TCT 972: Short Term Outcomes of Transcatheter Tricuspid Valve Interventions on Post-Procedural Length of Hospital Stay, Readmission for HF and Procedure Success if an Intracardiac Device Is Present

TCT 944: Left Ventricular Outflow Tract Impact on Transcatheter Mitral Valve Interventions

Transcatheter Tricuspid Valve Interventions in Denmark with 4D ICE imaging

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content